Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
PICOLO is a double blind placebo controlled phase II dose ranging, dose escalating study in
patients of Blalock-Taussig age categories (neonates and infants/toddlers), to determine the
dose providing inhibition of platelet aggregation similar to adults.